Blocking Orai1 constitutive activity inhibits B-cell cancer migration and synergistically acts with drugs to reduce B-CLL cell survival
J. Scaviner, C. Bagacean, B. Christian, Y. Renaudineau, O. Mignen, S. Abdoul-Azize
This study shows that inhibiting Orai1 reduces B-CLL cell survival and migration, and synergizes with existing drugs to enhance therapeutic effects.
bioRxiv · Dec 12, 2023Cancer Biology